Anand Anandkumar is the CEO and Managing Director of Bugworks Research, a startup that aims to discover novel treatment options for resistant bacterial infections. Anand was previously the Chairman and Managing Director of Cellworks Research India Pvt. Ltd, a company that pioneered the use of systems biology and semiconductor technologies in creating directed therapies in cancer care. He is a member of Eta-Kappa-Nu and Tau-Beta-Pi international engineering honours societies and is the co-inventor on patents ranging from satellite communication, pharmaceuticals to clean energy.
Anand has written about how the unregulated use of antibiotics has given rise to superbugs – a bacteria that can resist antibiotics. He has detailed how as a community, India has abused antibiotics by overusing them without prescriptions, filling its protein food chain with them, and then dumping pharmaceutical waste from antibiotic plants into the country’s water streams.
He is a passionate scientist and a humanitarian at heart. Anand believes that for science and scientific innovation to be at its best, it must be driven by the values of compassion and humanity.